Zobrazeno 1 - 10
of 614
pro vyhledávání: '"U. Havemann"'
Autor:
X. M. Hart, S. Heesen, C. N. Schmitz, S. Dörfler, D. Wedekind, G. Gründer, C. Hiemke, U. Havemann-Reinecke
Publikováno v:
European Archives of Psychiatry and Clinical Neuroscience. 273:75-83
The selective serotonin reuptake inhibitor escitalopram (ESC) is indicated for the treatment of major depressive disorder (MDD) and of generalized anxiety disorder (GAD). Monitoring of blood levels (BLs) is strongly indicated due to ESC’s high inte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::880846f4a52182b600dc7d30f02666ee
https://doi.org/10.1007/s00406-022-01491-9
https://doi.org/10.1007/s00406-022-01491-9
Autor:
X.M. Lense, G. Gründer, U. Havemann-Reinecke, G. Hefner, A. Menke, R. Mössner, M. Scherf-Clavel, G. Schoretsanitis, C. Hiemke, X.M. Hart
Publikováno v:
Pharmacopsychiatry.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e7f4d3dd62b4be364614b31ac3b775f0
https://doi.org/10.1055/s-0042-1747655
https://doi.org/10.1055/s-0042-1747655
Autor:
K. Wesner, C. Hiemke, N. Bergemann, M. Gerlach, U. Havemann-Reinecke, X.M. Lense, T.G. Riemer, G. Schoretsanitis, M. Uhr, G. Zernig, G. Gründer, X.M. Hart
Publikováno v:
Pharmacopsychiatry.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01a30f34f601c46894b9a78998507ae6
https://doi.org/10.1055/s-0042-1747666
https://doi.org/10.1055/s-0042-1747666
Publikováno v:
Pharmacopsychiatry.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7708bfd929ec0bf5ecafa3aa07062194
https://doi.org/10.1055/s-0042-1747644
https://doi.org/10.1055/s-0042-1747644
Autor:
X.M. Hart, C. Hiemke, H.W. Clement, A. Conca, L. Eichentopf, F. Faltraco, V. Florio, J. Grüner, U. Havemann-Reinecke, X. Lense, E. Molden, M. Paulzen, T.G. Riemer, G. Schoretsanitis, G. Gründer
Publikováno v:
Pharmacopsychiatry.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::089ecb943ee57f531f2e290396675a68
https://doi.org/10.1055/s-0042-1747652
https://doi.org/10.1055/s-0042-1747652
Autor:
L. Eichentopf, C. Hiemke, A. Conca, J. Engelmann, M. Gerlach, U. Havemann-Reinecke, G. Hefner, V. Florio, M. Kuzin, K. Lieb, M. Reis, T.G. Riemer, A. Seretti, G. Schoretsanitis, G. Zernig, G. Gründer, X. M. Hart
Publikováno v:
Pharmacopsychiatry.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9eee2ae5de552d3522fdd3ea46d72639
https://doi.org/10.1055/s-0042-1747647
https://doi.org/10.1055/s-0042-1747647
Publikováno v:
Sucht. feb2023, Vol. 69 Issue 1, p50-50. 1p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
U. Havemann-Reinecke, J. Tomas-Roig
Publikováno v:
Psychoneuroendocrinology, 2019, vol. 102, p. 1-8
Articles publicats (IdIBGi)
DUGiDocs – Universitat de Girona
instname
Articles publicats (IdIBGi)
DUGiDocs – Universitat de Girona
instname
Repeated exposure to life stressors can overwhelm the body’s capacity to restore homeostasis and result in severe negative consequences. Cannabinoid CB1 receptors are highly expressed in the Central Nervous System (CNS) and regulate both glucocorti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0ae802e34c42f11d10f43f0f1d1833c
https://doi.org/10.1016/j.psyneuen.2018.11.023
https://doi.org/10.1016/j.psyneuen.2018.11.023
Autor:
L. Eichentopf, C. Hiemke, G. Hefner, G. Schoretsanitis, M. Kuzin, G. Zernig, U. Havemann-Reinecke, M. Gerlach, A. Conca, G. Gründer, X. Hart
Publikováno v:
European Neuropsychopharmacology. 53:S507-S508
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::041f936f114c7e583507d48d831a96f3
https://doi.org/10.1016/j.euroneuro.2021.10.653
https://doi.org/10.1016/j.euroneuro.2021.10.653